Proteomics International Laboratories Ltd News

Proteomics International Partners With University of Oxford to Advance Endometriosis Study

Predictive diagnostics specialist Proteomics International Laboratories (ASX: PIQ) has signed an agreement with the University of Oxford to acquire approximately 600 patient plasma samples for a study into endometriosis.

Small CapsMar 25 08:13

Proteomics International Signs Agreement With University of Oxford for Endometriosis Study

Proteomics International Laboratories (ASX:PIQ) has partnered with the University of Oxford to acquire approximately 600 patient plasma samples for further clinical validation of its PromarkerEndo blo

MT NewswiresMar 25 07:50

Proteomics Says PromarkerD's US Launch Delayed

Proteomics International Laboratories (ASX:PIQ) said the US roll out of its PromarkerD predictive test for diabetic kidney disease, originally planned for Q2 of 2024, is now "likely to be delayed," ac

MT NewswiresMar 19 17:23

Proteomics International Laboratories Downgraded to Hold From Speculative Buy by Morgans

Proteomics International Laboratories Downgraded to Hold From Speculative Buy by Morgans

Dow JonesMar 12 09:34

Proteomics International Laboratories Secures ISO 13485 Certification Renewal

Medical technology company Proteomics International Laboratories (ASX:PIQ) secured ISO 13485 recertification, which is valid for three years, according to a filing with the Australian Securities Excha

MT NewswiresMar 6 11:41

Proteomics International Laboratories Narrows Fiscal H1 Loss

Proteomics International Laboratories (ASX:PIQ) reported Friday a net loss of AU$3.8 million in the six months ended Dec. 31, 2023, narrowing from AU$4.0 million a year earlier. Loss per share remaine

MT NewswiresFeb 23 18:27

Proteomics International's Blood Test for Throat Cancer Undergoes Biomarker Validation

Proteomics International Laboratories (ASX:PIQ) said a panel validated the biomarkers for the company's novel PromarkerEso blood test for esophageal adenocarcinoma. The blood test targets both esophag

MT NewswiresFeb 1 16:12

Proteomics International Laboratories Raises AU$6.5 Million for Test Commercialization, Further Development; Shares Down 10%

Proteomics International Laboratories (ASX:PIQ) raised AU$6.5 million via an institutional placement of 8.6 million ordinary shares at AU$0.76 each. Proceeds will be used to commercialize the Promarke

MT NewswiresJan 23 10:58

Is Proteomics International Laboratories (ASX:PIQ) In A Good Position To Invest In Growth?

Yahoo FinanceJan 19 10:02

Proteomics Signs Deal to Sell PromarkerD in Chile; Shares Jump 5%

Proteomics International Laboratories (ASX:PIQ) entered into a licensing agreement for the distribution of the diabetic kidney disease blood test system PromarkerD in Chile, the medical technology com

MT NewswiresDec 20, 2023 09:40

Proteomics International Laboratories Receives More Than AU$1.8 Million R&D Tax Rebate

Proteomics International Laboratories (ASX:PIQ) received a research and development tax incentive of more than AU$1.8 million for 2022-23, according to a Thursday news release. Shares of the medical t

MT NewswiresNov 9, 2023 12:32

Proteomics International Price Target Raised 46% to A$2.42/Share by Morgans

Proteomics International Price Target Raised 46% to A$2.42/Share by Morgans

Dow JonesOct 2, 2023 06:13

Proteomics International Price Target Raised 11% to A$2.00/Share by Euroz Hartleys

Proteomics International Price Target Raised 11% to A$2.00/Share by Euroz Hartleys

Dow JonesSep 29, 2023 12:49

Proteomics International Laboratories Limited's (ASX:PIQ) Shift From Loss To Profit

Yahoo FinanceSep 22, 2023 04:00

Proteomics International Laboratories Requests Extension of Securities Trading Suspension

Proteomics International Laboratories' (ASX:PIQ) has requested the Australian bourse to extend the voluntary suspension of its securities pending an announcement related to a regulatory approval appli

MT NewswiresSep 20, 2023 17:26

Proteomics International Subsidiary Secures New Patent in Japan; Shares Fall 4%

Proteomics International Laboratories' (ASX:PIQ) subsidiary, OxiDx, secured a patent in Japan for its platform technology to measure oxidative stress, the diagnostic firm said on Monday. The patent si

MT NewswiresSep 4, 2023 10:46

Proteomics International Target Price Cut 6.2% to A$1.66/Share by Morgans>PIQ.AU

Proteomics International Target Price Cut 6.2% to A$1.66/Share by Morgans>PIQ.AU

Dow JonesAug 28, 2023 08:30

Investing in Proteomics International Laboratories (ASX:PIQ) Five Years Ago Would Have Delivered You a 329% Gain

Yahoo FinanceJun 28, 2023 07:28

Companies Like Proteomics International Laboratories (ASX:PIQ) Are In A Position To Invest In Growth

Yahoo FinanceMar 5, 2023 07:11

Investors in Proteomics International Laboratories (ASX:PIQ) Have Made a Solid Return of 285% Over the Past Three Years

Yahoo FinanceJan 19, 2023 06:38